Elaine Stead

Elaine is a Partner at Main Sequence, with a focus on healthcare. She has an investment track record spanning more than 80 startups across Australia, the United States and Southeast Asia.
Previously, Elaine served as Director of New Ventures and Entrepreneurship at the Australian National University, leading its startup and equity investment strategy. She has founded venture businesses including Blue Sky VC, Human VC and Tribe Global Ventures, advised state governments on innovation policy, and served on boards in Australia and the US.
Elaine holds a PhD in Biochemistry (Stem Cell Biology) and a BSc in Biochemistry and Microbiology, both from the University of Adelaide. Elaine sits on the Board of Main Sequence portfolio companies Kinoxis, Xoma, Currus and Macrobiome.
Portfolio
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.









